miR-423 Promotes Breast Cancer Invasion by Activating NF-κB Signaling

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Porter P. “Westernizing” women’s risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358:213–216. doi:10.1056/NEJMp070830718199859
   PubMed Web of Science ®Google Scholar
• Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30:1–12. doi:10.21147/j.issn.1000-9604.2018.01.0129545714
   PubMed Web of Science ®Google Scholar
• Krop IE, Kim SB, González-Martín A, et al. TH3RESA study collaborators. Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15:689–699. doi:10.1016/S1470-2045(14)70178-024793816
   PubMed Web of Science ®Google Scholar
• Lorusso G, Rüegg C. New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol. 2012;22:226–233. doi:10.1016/j.semcancer.2012.03.00722504658
   PubMed Web of Science ®Google Scholar
• Lee JH, Nan A. Combination drug delivery approaches in metastatic breast cancer. J Drug Deliv. 2012;2012:915375.22619725
   PubMedGoogle Scholar
• Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749–759. doi:10.1038/nri170316175180
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132:344–362. doi:10.1016/j.cell.2008.01.02018267068
   PubMed Web of Science ®Google Scholar
• Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86. doi:10.1186/1476-4598-12-8623915189
   PubMed Web of Science ®Google Scholar
• Huber MA, Azoitei N, Baumann B, et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004;14:569–581. doi:10.1172/JCI200421358
   Google Scholar
• Karin M. Nuclear factor-κB in cancer development and progression. Nature. 2006;441:431–436. doi:10.1038/nature0487016724054
   PubMed Web of Science ®Google Scholar
• Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune Responses. Annu Rev Immunol. 1998;16:225–260. doi:10.1146/annurev.immunol.16.1.2259597130
   PubMed Web of Science ®Google Scholar
• Sakai Y, Uchida K, Nakayama H. A20 and ABIN-3 possibly promote regression of trehalose 6,6ʹ-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1. Inflamm Res. 2012;61:245–253. doi:10.1007/s00011-011-0406-622173278
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27:5848–5856. doi:10.1200/JCO.2009.24.031719884536
   PubMed Web of Science ®Google Scholar
• Ruvkun G. Clarifications on miRNA and cancer. Science. 2006;311:36–37. doi:10.1126/science.311.5757.36d
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944–13949. doi:10.1073/pnas.050665410216166262
   PubMed Web of Science ®Google Scholar
• Godlewski J, Nowicki MO, Bronisz A, et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008;68:9125–9130. doi:10.1158/0008-5472.CAN-08-262919010882
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–269. doi:10.1038/nrc184016557279
   PubMed Web of Science ®Google Scholar
• Rutnam ZJ, Yang BB. The non-coding 3ʹ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J Cell Sci. 2012;125:2075–2085. doi:10.1242/jcs.10081822637644
   PubMed Web of Science ®Google Scholar
• Jiang S, Zhang HW, Lu MH, et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 2010;70:3119–3127. doi:10.1158/0008-5472.CAN-09-425020354188
   PubMed Web of Science ®Google Scholar
• Li S, Zeng A, Hu Q, Yan W, Liu Y, You Y. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Neuro Oncol. 2017;19:55–65. doi:10.1093/neuonc/now12927471108
   PubMed Web of Science ®Google Scholar
• Stiuso P, Potenza N, Lombardi A, et al. MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib. Mol Ther Nucleic Acids. 2015;4:e233. doi:10.1038/mtna.2015.825782064
   PubMedGoogle Scholar
• Fang Z, Tang J, Bai Y, et al. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. J Exp Clin Cancer Res. 2015;34:86. doi:10.1186/s13046-015-0198-626297223
   PubMed Web of Science ®Google Scholar
• Banks CA, Boanca G, Lee ZT, et al. TNIP2 is a hub protein in the NF-κB network with both protein and RNA mediated interactions. Mol Cell Proteomics. 2016;15:3435–3449. doi:10.1074/mcp.M116.06050927609421
   PubMed Web of Science ®Google Scholar
• Huang L, Verstrepen L, Heyninck K, et al. ABINs inhibit EGF receptor-mediated NF-κB activation and growth of EGF receptor-overexpressing tumour cells. Oncogene. 2008;27:6131–6140. doi:10.1038/onc.2008.20818622428
   PubMed Web of Science ®Google Scholar
• Van Huffel S, Delaei F, Heyninck K, De Valck D, Beyaert R. Identification of a novel A20-binding inhibitor of nuclear Factor-κB activation termed ABIN-2. J Biol Chem. 2001;276:30216–30223. doi:10.1074/jbc.M10004820011390377
   PubMed Web of Science ®Google Scholar
• Tan G, Wu L, Tan J, et al. MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway. Sci Rep. 2016;6:22328. doi:10.1038/srep2232826928365
   PubMed Web of Science ®Google Scholar
• Dong G, Chanudet E, Zeng N, et al. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma. Clin Cancer Res. 2011;17:1440–1451. doi:10.1158/1078-0432.CCR-10-185921266526
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhu HQ, Ma CQ, et al. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression. Biomed Pharmacother. 2016;79:315–320. doi:10.1016/j.biopha.2016.02.02527044843
   PubMed Web of Science ®Google Scholar
• Liu C, Wang L, Chen W, et al. USP35 activated by miR let-7a inhibits cell proliferation and NF-κB activation through stabilization of ABIN-2. Oncotarget. 2015;6:27891–27906. doi:10.18632/oncotarget.445126348204
   PubMedGoogle Scholar
• Gluck S. The prevention and management of distant metastases in women with breast cancer. Cancer Invest. 2007;25:6–13. doi:10.1080/0735790070122697417364551
   PubMed Web of Science ®Google Scholar
• Tu CC, Cheng LH, Hsu HH, et al. Activation of snail and EMT-like signaling via the IKKαβ/NF-κB pathway in apicidin-resistant HA22T hepatocellular carcinoma cells. Chin J Physiol. 2013;56:326–333. doi:10.4077/CJP.2013.BAB15824495179
   PubMed Web of Science ®Google Scholar
• Kim JH, Park S, Chung H, Oh S. Wnt5a attenuates the pathogenic effects of the Wnt/β-catenin pathway in human retinal pigment epithelial cells via down-regulating β-catenin and snail. BMB Rep. 2015;48:525–530. doi:10.5483/BMBRep.2015.48.9.14026246285
   PubMed Web of Science ®Google Scholar
• Zhang C, Klymkowsky MW. Unexpected functional redundancy between Twist and Slug (Snail2) and their feedback regulation of NF-κB via Nodal and Cerberus. Dev Biol. 2009;331:340–349. doi:10.1016/j.ydbio.2009.04.01619389392
   PubMed Web of Science ®Google Scholar
• Tan Z, Zheng H, Liu X, et al. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer. Oncotarget. 2016;7:24076–24087. doi:10.18632/oncotarget.811926992223
   PubMedGoogle Scholar
• Jiang L, Yu L, Zhang X, et al. miR-892b silencing activates NF-kappaB and promotes aggressiveness in breast cancer. Cancer Res. 2016;76:1101–1111. doi:10.1158/0008-5472.CAN-15-177026747895
   PubMed Web of Science ®Google Scholar
• Jiang L, Lin C, Song L, et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. J Clin Invest. 2012;122:33–47. doi:10.1172/JCI5884922156201
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple J, Welch WR, et al. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8. doi:10.1056/NEJM199101033240101
   PubMed Web of Science ®Google Scholar
• Wang R, Li G, Zhuang G, Sun S, Song Z. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer. Diagn Pathol. 2019;14:53. doi:10.1186/s13000-019-0831-331164163
   PubMed Web of Science ®Google Scholar
• Lin H, Lin T, Lin J, et al. Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19. Gene. 2019;88:93–97. doi:10.1016/j.gene.2018.11.021
   Google Scholar
• Hui AB, Lenarduzzi M, Krushel T, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 2010;16:1129–1139. doi:10.1158/1078-0432.CCR-09-216620145181
   PubMed Web of Science ®Google Scholar
• Jia W, Yu T, An Q, Cao X, Pan H. MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis. Exp Ther Med. 2018;16:1225–1231. doi:10.3892/etm.2018.628830116373
   PubMed Web of Science ®Google Scholar
• Tang X, Zeng X, Huang Y, et al. miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer. Exp Ther Med. 2018;15:4723–4730. doi:10.3892/etm.2018.601529849781
   PubMed Web of Science ®Google Scholar
• Sun X, Huang T, Zhang C, et al. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p. Cell Cycle. 2019;18:1908–1924. doi:10.1080/15384101.2019.163264131213129
   PubMed Web of Science ®Google Scholar
• Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, Griffiths LR. A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics. 2012;9:115–118.22593246
   PubMed Web of Science ®Google Scholar
• Zhao H, Gao A, Zhang Z, et al. Genetic analysis and preliminary function study of miR-423 in breast cancer. Tumour Biol. 2015;36:4763–4771. doi:10.1007/s13277-015-3126-725663458
   PubMedGoogle Scholar
• Farazi TA, Horlings HM, Ten Hoeve JJ, et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 2011;71:4443–4453. doi:10.1158/0008-5472.CAN-11-060821586611
   PubMed Web of Science ®Google Scholar
• Sun G, Ding X, Bi N, et al. Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma. PLoS Genet. 2019;15:e1007888. doi:10.1371/journal.pgen.100788830707694
   PubMed Web of Science ®Google Scholar